DRUG
Bright Minds Biosciences
DRUG
DRUG
47 hedge funds and large institutions have $137M invested in Bright Minds Biosciences in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
27% less capital invested
Capital invested by funds: $188M → $137M (-$51.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
47
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$6.27M | |
| 2 | +$1.72M | |
| 3 | +$1.03M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$959K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$768K |
Top Sellers
| 1 | -$7.45M | |
| 2 | -$2.43M | |
| 3 | -$947K | |
| 4 |
Goldman Sachs
New York
|
-$802K |
| 5 |
PA
Perceptive Advisors
New York
|
-$718K |